MangoceuticalsMGRX

13F holders, Q4 2025 (December 31)
18holders +7
10new positions
3sold out
$0.74avg. 13F price*

At the end of Q4 2025, 18 institutions reported holding Mangoceuticals Inc. (MGRX) in their 13F filings, up 7 from Q3 2025. 10 opened new positions and 3 sold out. The largest holders were Armistice Capital, LLC ($1.1M), Vanguard Group Inc. ($362K) and Ikarian Capital, LLC ($102K).

Company
Mangoceuticals Inc.
CUSIP
56270V205
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q3 2024: 1Q3 2024Q4 2024: 9Q4 2024Q1 2025: 8Q1 2025Q2 2025: 10Q2 2025Q3 2025: 11Q3 2025Q4 2025: 18Q4 2025Q1 2026: 18Q1 2026Q2 2026: 18Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions10$1.3M
Exits3$68K

All 13F filers, Q3 2025 → Q4 2025: 2,193,595 shares bought and 31,128 shares sold, net +2,162,467 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 18 holders
Armistice Capital, LLC 0.03% New 1,536,000 $1.1M
Vanguard Group Inc. 0.00% Add +155.0% 489,532 $362K
Ikarian Capital, LLC 0.01% New 138,146 $102K
Geode Capital Management, LLC 0.00% Add +23.1% 108,322 $80K
Jane Street Group, LLC 0.00% New 47,503 $35K
UBS Group AG 0.00% Add +1538800.0% 46,167 $34K
Boothbay Fund Management, LLC 0.00% New 38,441 $28K
Northern Trust Corp. 0.00% Add +98.2% 37,579 $28K
Ackerman Capital Advisors, LLC 0.01% No change 34,500 $26K
Virtu Financial LLC 0.00% New 33,462 $25K
Sunbelt Securities, Inc. 0.00% Add +71.4% 12,000 $9K
Csenge Advisory Group 0.00% New 10,000 $7K
Osaic Holdings, Inc. 0.00% No change 2,885 $2K
Tower Research Capital LLC (TRC) 0.00% New 1,002 $741
Morgan Stanley 0.00% New 1,000 $740
Fortitude Family Office, LLC 0.00% New 378 $280
Bank of America Corp. 0.00% Reduce -39.2% 107 $79
Citigroup Inc. 0.00% New 1 $1

"% of holder's portfolio" is MGRX's weight in each manager's 13F, not the share of Mangoceuticals Inc. the manager owns.